Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803852316> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2803852316 abstract "Background: Palbociclib is a CDK 4/6 inhibitor approved in combination with letrozole in hormone-positive breast cancer. The START PDX platform comprises over 1300 fully annotated models, including a breast cancer panel of over 100 models representing each disease subtype: ~35 ER+, 20 HER2+, and 45 TNBC models. To better understand activity of CDK 4/6 inhibitors in breast cancer we screened our breast panel with single-agent palbociclib. The goal of this study was to determine and compare efficacy of a CDK 4/6 inhibitor in models representative of relevant subtypes of human breast cancer. Methods: START-PDX models were established from tissue biopsies or tissue samples taken from breast cancer patients. Sensitivity of 100 breast tumor models to single-agent palbociclib administered orally once daily at 75 mg/kg for a minimum of twenty-eight days was evaluated in a coclinical screen format. Study endpoints included mean tumor volume and time from treatment initiation with %T/C values and tumor regression reported at study completion. Results: ER+ models showed variable sensitivity to palbociclib treatment, including ST897, ST986, and ST313, which reported tumor regressions. Interestingly, two ER+ harboring an ESR1 mutation and developed in the presence (ST941 and ST2177) or absence (ST941/HI and ST2177/HI) of exogenous estradiol reported differential sensitivity with the hormone-independent (HI) models more sensitive. Several TNBC models including ST319 and ST1394 reported sensitivity to palbociclib with %T/C values of 20% and 25%, respectively. Conclusion: We screened a panel of breast PDX models with the CDK 4/6 inhibitor palbociclib and identified activity in all breast cancer subtypes. In addition, we found a differential response in ER+, ESR1-mutant models developed in the presence and absence of exogenous estradiol. Exploration of biomarkers of sensitivity is ongoing. Citation Format: Alyssa Moriarty, Amanda Mangold, Ileana Munoz, Megan Groves, Marcus Guerra, Melissa Rundle, Kyriakos P. Papadopoulos, Drew Rasco, Anthony W. Tolcher, Amita Patnaik, Michael J. Wick. Evaluation and comparison of the CDK 4/6 inhibitor palbociclib in a panel of PDX models representing hormone-positive and -negative breast cancer [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2017 Oct 26-30; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr A210." @default.
- W2803852316 created "2018-06-01" @default.
- W2803852316 creator A5001921842 @default.
- W2803852316 creator A5005325532 @default.
- W2803852316 creator A5014259549 @default.
- W2803852316 creator A5016675333 @default.
- W2803852316 creator A5022467575 @default.
- W2803852316 creator A5045085990 @default.
- W2803852316 creator A5054288578 @default.
- W2803852316 creator A5060992997 @default.
- W2803852316 creator A5070570779 @default.
- W2803852316 creator A5073134832 @default.
- W2803852316 creator A5073327600 @default.
- W2803852316 date "2018-01-01" @default.
- W2803852316 modified "2023-09-27" @default.
- W2803852316 title "Abstract A210: Evaluation and comparison of the CDK 4/6 inhibitor palbociclib in a panel of PDX models representing hormone-positive and -negative breast cancer" @default.
- W2803852316 doi "https://doi.org/10.1158/1535-7163.targ-17-a210" @default.
- W2803852316 hasPublicationYear "2018" @default.
- W2803852316 type Work @default.
- W2803852316 sameAs 2803852316 @default.
- W2803852316 citedByCount "0" @default.
- W2803852316 crossrefType "proceedings-article" @default.
- W2803852316 hasAuthorship W2803852316A5001921842 @default.
- W2803852316 hasAuthorship W2803852316A5005325532 @default.
- W2803852316 hasAuthorship W2803852316A5014259549 @default.
- W2803852316 hasAuthorship W2803852316A5016675333 @default.
- W2803852316 hasAuthorship W2803852316A5022467575 @default.
- W2803852316 hasAuthorship W2803852316A5045085990 @default.
- W2803852316 hasAuthorship W2803852316A5054288578 @default.
- W2803852316 hasAuthorship W2803852316A5060992997 @default.
- W2803852316 hasAuthorship W2803852316A5070570779 @default.
- W2803852316 hasAuthorship W2803852316A5073134832 @default.
- W2803852316 hasAuthorship W2803852316A5073327600 @default.
- W2803852316 hasConcept C121608353 @default.
- W2803852316 hasConcept C124320809 @default.
- W2803852316 hasConcept C126322002 @default.
- W2803852316 hasConcept C143998085 @default.
- W2803852316 hasConcept C2775930923 @default.
- W2803852316 hasConcept C2777176818 @default.
- W2803852316 hasConcept C2778298596 @default.
- W2803852316 hasConcept C2778812593 @default.
- W2803852316 hasConcept C2779744173 @default.
- W2803852316 hasConcept C29537977 @default.
- W2803852316 hasConcept C502942594 @default.
- W2803852316 hasConcept C530470458 @default.
- W2803852316 hasConcept C71924100 @default.
- W2803852316 hasConceptScore W2803852316C121608353 @default.
- W2803852316 hasConceptScore W2803852316C124320809 @default.
- W2803852316 hasConceptScore W2803852316C126322002 @default.
- W2803852316 hasConceptScore W2803852316C143998085 @default.
- W2803852316 hasConceptScore W2803852316C2775930923 @default.
- W2803852316 hasConceptScore W2803852316C2777176818 @default.
- W2803852316 hasConceptScore W2803852316C2778298596 @default.
- W2803852316 hasConceptScore W2803852316C2778812593 @default.
- W2803852316 hasConceptScore W2803852316C2779744173 @default.
- W2803852316 hasConceptScore W2803852316C29537977 @default.
- W2803852316 hasConceptScore W2803852316C502942594 @default.
- W2803852316 hasConceptScore W2803852316C530470458 @default.
- W2803852316 hasConceptScore W2803852316C71924100 @default.
- W2803852316 hasLocation W28038523161 @default.
- W2803852316 hasOpenAccess W2803852316 @default.
- W2803852316 hasPrimaryLocation W28038523161 @default.
- W2803852316 hasRelatedWork W1989061029 @default.
- W2803852316 hasRelatedWork W2017589574 @default.
- W2803852316 hasRelatedWork W2033888421 @default.
- W2803852316 hasRelatedWork W2092424194 @default.
- W2803852316 hasRelatedWork W2346903055 @default.
- W2803852316 hasRelatedWork W2403122591 @default.
- W2803852316 hasRelatedWork W2477713715 @default.
- W2803852316 hasRelatedWork W2742112316 @default.
- W2803852316 hasRelatedWork W2792709310 @default.
- W2803852316 hasRelatedWork W2886898708 @default.
- W2803852316 hasRelatedWork W2887682467 @default.
- W2803852316 hasRelatedWork W2887970367 @default.
- W2803852316 hasRelatedWork W2901425242 @default.
- W2803852316 hasRelatedWork W2914130331 @default.
- W2803852316 hasRelatedWork W2916617432 @default.
- W2803852316 hasRelatedWork W2917464640 @default.
- W2803852316 hasRelatedWork W2956076791 @default.
- W2803852316 hasRelatedWork W2993586750 @default.
- W2803852316 hasRelatedWork W3005578984 @default.
- W2803852316 hasRelatedWork W3013880900 @default.
- W2803852316 isParatext "false" @default.
- W2803852316 isRetracted "false" @default.
- W2803852316 magId "2803852316" @default.
- W2803852316 workType "article" @default.